These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37365776)

  • 1. Handling misclassified stratification variables in the analysis of randomised trials with continuous outcomes.
    Yelland LN; Louise J; Kahan BC; Morris TP; Lee KJ; Sullivan TR
    Stat Med; 2023 Aug; 42(19):3529-3546. PubMed ID: 37365776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Categorisation of continuous covariates for stratified randomisation: How should we adjust?
    Sullivan TR; Morris TP; Kahan BC; Cuthbert AR; Yelland LN
    Stat Med; 2024 May; 43(11):2083-2095. PubMed ID: 38487976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjusting for multiple prognostic factors in the analysis of randomised trials.
    Kahan BC; Morris TP
    BMC Med Res Methodol; 2013 Jul; 13():99. PubMed ID: 23898993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mind the gap: covariate constrained randomisation can protect against substantial power loss in parallel cluster randomised trials.
    Kristunas C; Grayling M; Gray LJ; Hemming K
    BMC Med Res Methodol; 2022 Apr; 22(1):111. PubMed ID: 35413793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimisation for the design of parallel cluster-randomised trials: An evaluation of balance in cluster-level covariates and numbers of clusters allocated to each arm.
    Martin J; Middleton L; Hemming K
    Clin Trials; 2023 Apr; 20(2):111-120. PubMed ID: 36661245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survey design and analysis considerations when utilizing misclassified sampling strata.
    Mitani AA; Mercaldo ND; Haneuse S; Schildcrout JS
    BMC Med Res Methodol; 2021 Jul; 21(1):145. PubMed ID: 34247586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of covariate misclassification using generalized linear regression under covariate-adaptive randomization.
    Fan L; Yeatts SD; Wolf BJ; McClure LA; Selim M; Palesch YY
    Stat Methods Med Res; 2018 Jan; 27(1):20-34. PubMed ID: 26596352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and reporting of recruitment, randomisation and treatment errors in clinical trials: A systematic review.
    Yelland LN; Kahan BC; Dent E; Lee KJ; Voysey M; Forbes AB; Cook JA
    Clin Trials; 2018 Jun; 15(3):278-285. PubMed ID: 29638145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applying the intention-to-treat principle in practice: Guidance on handling randomisation errors.
    Yelland LN; Sullivan TR; Voysey M; Lee KJ; Cook JA; Forbes AB
    Clin Trials; 2015 Aug; 12(4):418-23. PubMed ID: 26033877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating tests for cluster-randomized trials with few clusters under generalized linear mixed models with covariate adjustment: A simulation study.
    Qiu H; Cook AJ; Bobb JF
    Stat Med; 2024 Jan; 43(2):201-215. PubMed ID: 37933766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of misclassification on covariate-adaptive randomized clinical trials.
    Wang T; Ma W
    Biometrics; 2021 Jun; 77(2):451-464. PubMed ID: 32453885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
    Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
    Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using audit information to adjust parameter estimates for data errors in clinical trials.
    Shepherd BE; Shaw PA; Dodd LE
    Clin Trials; 2012 Dec; 9(6):721-9. PubMed ID: 22848072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Bayesian Hybrid Adaptive Randomisation Design for Clinical Trials with Survival Outcomes.
    Moatti M; Chevret S; Zohar S; Rosenberger WF
    Methods Inf Med; 2016; 55(1):4-13. PubMed ID: 26404511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review of randomisation method use in RCTs and association of trial design characteristics with method selection.
    Bruce CL; Juszczak E; Ogollah R; Partlett C; Montgomery A
    BMC Med Res Methodol; 2022 Dec; 22(1):314. PubMed ID: 36476324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing for treatment effect in covariate-adaptive randomized trials with generalized linear models and omitted covariates.
    Li Y; Ma W; Qin Y; Hu F
    Stat Methods Med Res; 2021 Sep; 30(9):2148-2164. PubMed ID: 33899607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of methods to adjust for continuous covariates in the analysis of randomised trials.
    Kahan BC; Rushton H; Morris TP; Daniel RM
    BMC Med Res Methodol; 2016 Apr; 16():42. PubMed ID: 27068456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of dichotomization of skewed adjustment covariates in the analysis of clinical trials.
    Herschtal A
    BMC Med Res Methodol; 2023 Mar; 23(1):60. PubMed ID: 36907867
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.